Evidence map›Paper›PMID 42150760›Full record

ReviewNeuro-oncology2026

The emerging roles of cerebral pericytes in brain metastasis.

Chanawee Hirunpattarasilp, Herbert B Newton

Abstract readReview
In one paragraph

Review in Neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chanawee HirunpattarasilpDepartment of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.ORCID 0000-0003-1262-9466
Herbert B NewtonNeuro-Oncology Program and Brain Tumor Institute, University Hospitals of Cleveland Medical Center, Seidman Cancer Center, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastases are a prevalent disease found in up to 40% of patients with solid cancers, and are associated with significant morbidity and mortality. Current treatment options for brain metastases are limited, especially because the tumor is protected by the blood-tumor barrier that prevents the penetration of chemotherapeutic agents. Understanding the brain metastatic process and the cells involved is required to discover new treatment approaches. One interesting therapeutic target is mural cells called pericytes, given their importance in maintaining the blood-brain barrier, regulating blood flow, modulating the immune response, and promoting angiogenesis in normal brain physiology. The role of cerebral pericytes in the initiation and maintenance of brain metastases is not well understood. In this review, we discuss the current understanding of the steps in the metastatic process and the roles of cerebral pericytes at each step, especially premetastatic niche formation, cancer cell extravasation, brain micrometastasis formation, and maintenance of macrometastasis and the tumor microenvironment. This study aims to provide a comprehensive understanding of the importance of brain pericytes in brain metastasis formation and maintenance, offer a perspective on the further investigations that are needed, and propose possible clinical implications for the treatment of brain metastases.

Indexed as

BrainBrain NeoplasmsPericytesAnimalsBlood-Brain BarrierHumansNeovascularization, PathologicTumor Microenvironmentbrain metastasispericytespremetastatic nichetumor microenvironment

Identifiers

PMID42150760
PMCPMC13550668

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.